This may explain why tumors with low-frequency EGFR mutations still respond to EGFR-TKIs in some cases [122] and provide a potential new tool for the prognosis and guidance of treatment for EGFR-mutated NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.